LRRC32 and malignant colon neoplasm: It has been shown that platelet-derived TGF-β has an immunosuppressive effect, primarily affecting T cells, and that the deletion of Lrrc32 (the gene encoding GARP) enhances the protective effect of the immune system against both melanoma and colon cancer.